KVP Capital Advisors »

Fulcrum Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $566k 50k 11.31

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
ADAR1 Capital Management
Dimensional Fund Advisors
Ikarian Capital
Standard Life Aberdeen
Geode Capital Management

View all funds holding Fulcrum Therapeutics